147 related articles for article (PubMed ID: 24480967)
21. In vitro culture of isolated primary hepatocytes and stem cell-derived hepatocyte-like cells for liver regeneration.
Hu C; Li L
Protein Cell; 2015 Aug; 6(8):562-74. PubMed ID: 26088193
[TBL] [Abstract][Full Text] [Related]
22. Generation and differentiation of induced pluripotent stem cells reveal ankylosing spondylitis risk gene expression in bone progenitors.
Layh-Schmitt G; Lu S; Navid F; Brooks SR; Lazowick E; Davis KM; Montagna C; Gadina M; Colbert RA
Clin Rheumatol; 2017 Jan; 36(1):143-154. PubMed ID: 27864696
[TBL] [Abstract][Full Text] [Related]
23. Exosomes secreted by human-induced pluripotent stem cell-derived mesenchymal stem cells attenuate limb ischemia by promoting angiogenesis in mice.
Hu GW; Li Q; Niu X; Hu B; Liu J; Zhou SM; Guo SC; Lang HL; Zhang CQ; Wang Y; Deng ZF
Stem Cell Res Ther; 2015 Apr; 6(1):10. PubMed ID: 26268554
[TBL] [Abstract][Full Text] [Related]
24. Generating autologous hematopoietic cells from human-induced pluripotent stem cells through ectopic expression of transcription factors.
Hwang Y; Broxmeyer HE; Lee MR
Curr Opin Hematol; 2017 Jul; 24(4):283-288. PubMed ID: 28383341
[TBL] [Abstract][Full Text] [Related]
25. Systematic review of induced pluripotent stem cell technology as a potential clinical therapy for spinal cord injury.
Kramer AS; Harvey AR; Plant GW; Hodgetts SI
Cell Transplant; 2013; 22(4):571-617. PubMed ID: 22944020
[TBL] [Abstract][Full Text] [Related]
26. hiPSC-derived iMSCs: NextGen MSCs as an advanced therapeutically active cell resource for regenerative medicine.
Sabapathy V; Kumar S
J Cell Mol Med; 2016 Aug; 20(8):1571-88. PubMed ID: 27097531
[TBL] [Abstract][Full Text] [Related]
27. Therapeutic Application of Placental Mesenchymal Stem Cells Reprogrammed Neurospheres in Spinal Cord Injury of SCID.
Sabapathy V; Herbert FJ; Kumar S
Methods Mol Biol; 2017; 1553():91-113. PubMed ID: 28229410
[TBL] [Abstract][Full Text] [Related]
28. Efficient generation of transgene- and feeder-free induced pluripotent stem cells from human dental mesenchymal stem cells and their chemically defined differentiation into cardiomyocytes.
Tan X; Dai Q; Guo T; Xu J; Dai Q
Biochem Biophys Res Commun; 2018 Jan; 495(4):2490-2497. PubMed ID: 29217199
[TBL] [Abstract][Full Text] [Related]
29. The use of stem cells in kidney disease.
Chhabra P; Brayman KL
Curr Opin Organ Transplant; 2009 Feb; 14(1):72-8. PubMed ID: 19337150
[TBL] [Abstract][Full Text] [Related]
30. Embryonic and induced pluripotent stem cells for lung regeneration.
Hawkins F; Kotton DN
Ann Am Thorac Soc; 2015 Mar; 12 Suppl 1():S50-3. PubMed ID: 25830836
[TBL] [Abstract][Full Text] [Related]
31. Improved cell survival and paracrine capacity of human embryonic stem cell-derived mesenchymal stem cells promote therapeutic potential for pulmonary arterial hypertension.
Zhang Y; Liao S; Yang M; Liang X; Poon MW; Wong CY; Wang J; Zhou Z; Cheong SK; Lee CN; Tse HF; Lian Q
Cell Transplant; 2012; 21(10):2225-39. PubMed ID: 22776744
[TBL] [Abstract][Full Text] [Related]
32. [Differentiation of pluripotent stem cells into male germ cells: An update].
Wang SY; Cui YG; Qin LJ
Zhonghua Nan Ke Xue; 2017 May; 23(5):468-472. PubMed ID: 29717842
[TBL] [Abstract][Full Text] [Related]
33. Cell aggregation optimizes the differentiation of human ESCs and iPSCs into pancreatic bud-like progenitor cells.
Toyoda T; Mae S; Tanaka H; Kondo Y; Funato M; Hosokawa Y; Sudo T; Kawaguchi Y; Osafune K
Stem Cell Res; 2015 Mar; 14(2):185-97. PubMed ID: 25665923
[TBL] [Abstract][Full Text] [Related]
34. Development of a Xeno-Free Feeder-Layer System from Human Umbilical Cord Mesenchymal Stem Cells for Prolonged Expansion of Human Induced Pluripotent Stem Cells in Culture.
Zou Q; Wu M; Zhong L; Fan Z; Zhang B; Chen Q; Ma F
PLoS One; 2016; 11(2):e0149023. PubMed ID: 26882313
[TBL] [Abstract][Full Text] [Related]
35. Apoptosis in Porcine Pluripotent Cells: From ICM to iPSCs.
Kim E; Hyun SH
Int J Mol Sci; 2016 Sep; 17(9):. PubMed ID: 27626414
[TBL] [Abstract][Full Text] [Related]
36. Current progress and potential practical application for human pluripotent stem cells.
Philonenko ES; Shutova MV; Chestkov IV; Lagarkova MA; Kiselev SL
Int Rev Cell Mol Biol; 2011; 292():153-96. PubMed ID: 22078961
[TBL] [Abstract][Full Text] [Related]
37. Human Gingival Integration-Free iPSCs; a Source for MSC-Like Cells.
Umezaki Y; Hashimoto Y; Nishishita N; Kawamata S; Baba S
Int J Mol Sci; 2015 Jun; 16(6):13633-48. PubMed ID: 26084043
[TBL] [Abstract][Full Text] [Related]
38. Human transgene-free amniotic-fluid-derived induced pluripotent stem cells for autologous cell therapy.
Jiang G; Di Bernardo J; Maiden MM; Villa-Diaz LG; Mabrouk OS; Krebsbach PH; O'Shea KS; Kunisaki SM
Stem Cells Dev; 2014 Nov; 23(21):2613-25. PubMed ID: 25014361
[TBL] [Abstract][Full Text] [Related]
39. Improved hematopoietic differentiation of primate embryonic stem cells by inhibition of the PI3K-AKT pathway under defined conditions.
Nii T; Marumoto T; Kohara H; Yamaguchi S; Kawano H; Sasaki E; Kametani Y; Tani K
Exp Hematol; 2015 Oct; 43(10):901-911.e4. PubMed ID: 26073521
[TBL] [Abstract][Full Text] [Related]
40. Nuclear reprogramming and induced pluripotent stem cells: a review for surgeons.
Qi SD; Smith PD; Choong PF
ANZ J Surg; 2014 Jun; 84(6):E1-11. PubMed ID: 23035845
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
